DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Operating cash flow — 10-Year History · Tickwind

DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Operating cash flow

DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.

-$539,187FY2025

Fiscal year	Value	YoY
FY2025	-$539,187	—

Source: SEC XBRL filings · For reference only · Not investment advice

More DMAAR financial trends

DMAAR Revenue DMAAR Net income DMAAR Net margin DMAAR Gross profit DMAAR Gross margin DMAAR Operating income DMAAR Operating margin DMAAR Free cash flow DMAAR Capital expenditures DMAAR Return on equity